YAP1 and melanoma: Single gene knock-outs showed modest re-sensitization to Vemurafenib, whereas simultaneous knockout of both YAP1 and TAZ revealed pronounced re-sensitization in MITFlow/AXLhigh melanoma cells (Fig. 2h).